IQVIA, formed through the merger of IMS Health and Quintiles, is a healthcare technology company headquartered in Danbury, Connecticut, and Durham, North Carolina. Founded originally as IMS Health in 1954, the company has evolved to provide comprehensive information, services, and technology solutions for the healthcare industry. IQVIA's core mission is to leverage data and advanced analytics to improve healthcare outcomes and drive innovation. Their product offerings include healthcare measurement, analytics, consulting, and technology services, targeting pharmaceutical companies, healthcare providers, and policymakers.
Notable affiliated individuals include founders Bill Frohlich and David Dubow, with Arthur Sackler having had a hidden ownership stake. The company has attracted significant investment from TPG Capital, CPP Investment Board, and Leonard Green & Partners. Key achievements include being the largest vendor of U.S. physician prescribing data and maintaining a robust revenue stream of $2.64 billion as of 2015. IQVIA's impact on the healthcare industry is substantial, providing critical insights and technology that enhance decision-making and patient care globally.

Viatris
viatris.com
McKesson
mckesson.com

Medidata Solutions

Syneos Health
syneoshealth.com

Health Catalyst
healthcatalyst.com

Quintiles
quintiles.com

Definitive Healthcare
definitivehc.com
Bristol Myers Squibb
bms.com

QI Healthcare
qihealthcare.com

iQure Pharma
iqurepharma.com

Premier
premierinc.com

Datavant
datavant.com

VisiQuate
visiquate.com

Allscripts
allscripts.com

Boston Health Economic Holdings
Companies similar to IQVIA include Viatris, McKesson, Medidata Solutions and Syneos Health.
IQVIA was founded in 1954.
IQVIA's headquarters is located in Durham, NC, US.
IQVIA's most recent funding round was for $500M (USD) in November 2023.
As of Nov 14, 2023, IQVIA has raised a total of $1.5B (USD).
IQVIA has 87,000 employees as of Feb 6, 2024.